CM
ATOS icon

Caption Management’s Atossa Therapeutics ATOS Stock Holding History

Caption Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,000
Closed -$66K – 1224
2023
Q4 		$66K Hold
5,000
– – 0.01% 1209
2023
Q3 		$55.2K Hold
5,000
– – 0.01% 1186
2023
Q2 		$94.5K Hold
5,000
– – 0.02% 984
2023
Q1 		$54.4K Buy
+5,000
New +$55.8K 0.01% 991
2022
Q1 		– Sell
-20,000
Closed -$480K – 1479
2021
Q4 		$480K Buy
20,000
+12,220
+157% +$447K 0.03% 1257
2021
Q3 		$380K Sell
7,780
-21,967
-74% -$1.28M 0.02% 1250
2021
Q2 		$2.82M Buy
29,747
+24,080
+425% +$1.27M 0.25% 560
2021
Q1 		$179K Buy
+5,667
New +$207K 0.02% 928

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return